...
首页> 外文期刊>Neuropeptides: An International Journal >Protective effect of the tachykinin NK2 receptor antagonist nepadutant in acute rectocolitis induced by diluted acetic acid in guinea-pigs.
【24h】

Protective effect of the tachykinin NK2 receptor antagonist nepadutant in acute rectocolitis induced by diluted acetic acid in guinea-pigs.

机译:速激肽NK2受体拮抗剂nepadutant在豚鼠中稀释的乙酸诱导的急性直肠炎中的保护作用。

获取原文
获取原文并翻译 | 示例

摘要

We have evaluated the potential protective activity of nepadutant, a selective tachykinin NK2 receptor antagonist, in a model of acute rectocolitis induced by an enema with 7.5% acetic acid in guinea-pigs. The injury was quantified visually by using a macroscopic injury score, and histologically by using a necrosis score. In addition, changes in myeloperoxidase activity, a marker for neutrophil infiltration, and plasma protein extravasation were evaluated. The injury caused by 7.5% acetic acid was mild, affecting the superficial layers and producing a strong edema of the submucosa. A single administration of nepadutant (0.3-10 mg/kg s.c., 1 h before acetic acid) markedly reduced the macroscopic damage and necrosis score and the increase in plasma protein extravasation induced by 7.5% acetic acid in the early phase of the injury. Single administration of nepadutant (3 mg/kg s.c.) reduced the macroscopic score and myeloperoxidase activity at the top (24 h) of inflammation. Repeated administration (3 mg/kg s.c. three times during 24 h) or co-administration of the tachykinin NK1 receptor antagonist MEN 11467 (3 mg/kg s.c.) did not enhance the antiulcer effect obtained with the single treatment with nepadutant. These data suggest the involvement of tachykinin NK2 receptors in the first phases of inflammation induced by acetic acid.
机译:我们已经评估了nepadutant(一种选择性速激肽NK2受体拮抗剂)在豚鼠中用7.5%乙酸灌肠诱发的急性直肠结肠炎模型中的潜在保护作用。通过使用宏观损伤评分在视觉上定量损伤,并且通过使用坏死评分在组织学上定量损伤。此外,评估了髓过氧化物酶活性的变化,嗜中性粒细胞浸润的标志物和血浆蛋白外渗。由7.5%乙酸引起的伤害是轻度的,影响浅表层并产生粘膜下层强烈的水肿。一次给予nepadutant(0.3-10 mg / kg s.c.,在乙酸之前1小时)显着降低了肉眼可见的宏观损伤和坏死评分,并在损伤的早期阶段由7.5%乙酸诱导了血浆蛋白外渗的增加。单独施用奈哌替丁(3 mg / kg s.c.)可降低炎症高峰期(24 h)的宏观评分和髓过氧化物酶活性。重复给药(24小时内3次,每次3 mg / kg s.c.)或速激肽NK1受体拮抗剂MEN 11467共同给药(3 mg / kg s.c.),均不能增强用尼巴丁坦单次治疗获得的抗溃疡作用。这些数据表明速激肽NK2受体参与了乙酸诱导的炎症的第一阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号